Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Xiao Fang Pharmaceutical CoSHSE:603207 -0.69%41 5-Year Yield-on-Cost % is 4.63 as of Aug. 31, 2026, which is 37% below its 10-year median of 7.39. GuruFocus rates SHSE:603207 with a GF Score™ of 41/100. The stock has 3 warning signs investors should review. Among 509 Drug Manufacturers companies, Shanghai Xiao Fang Pharmaceutical Co ranks better than 69.94% on this metric.
SHSE:603207's 5-Year Yield-on-Cost % is ranked better than 69.94% of 509
companies
in the Drug Manufacturers industry
Industry Median: 2.39
vs SHSE:603207: 4.63
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Shanghai Xiao Fang Pharmaceutical Co 5-Year Yield-on-Cost % Related Terms
SHSE:603207 vs ZTS: 5-Year Yield-on-Cost % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xiao Fang Pharmaceutical Co 5-Year Yield-on-Cost % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost % falls into.
Shanghai Xiao Fang Pharmaceutical Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a 5-Year Yield-on-Cost % of 4.63 as of Aug. 31, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. This is 37% below median its historical median of 7.39. Over the past decade, Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost % has ranged from 4.06 to 10.23. According to the industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #153 out of 509 companies in the Drug Manufacturers industry, placing it in the top 30.1%.
Is Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost % too high?
Shanghai Xiao Fang Pharmaceutical Co's current 5-Year Yield-on-Cost % of 4.63 is 37% below median its 10-year median of 7.39. Over the past 10 years, this metric has ranged from a low of 4.06 to a high of 10.23. The Drug Manufacturers industry median 5-Year Yield-on-Cost % is 2.39. Shanghai Xiao Fang Pharmaceutical Co's value of 4.63 is 93.7% above this industry median. Based on the distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #153 out of 509 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shanghai Xiao Fang Pharmaceutical Co has a GF Score™ of 41/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xiao Fang Pharmaceutical Co's 5-Year Yield-on-Cost % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Shanghai Xiao Fang Pharmaceutical Co ranks #153 out of 509 companies for 5-Year Yield-on-Cost %. This puts Shanghai Xiao Fang Pharmaceutical Co in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.39. Shanghai Xiao Fang Pharmaceutical Co's value of 4.63 is 93.7% above this benchmark. Historically, Shanghai Xiao Fang Pharmaceutical Co's own 5-Year Yield-on-Cost % has ranged from 4.06 to 10.23 over the past decade. While the company's 10-year median is 7.39 vs. the industry median of 2.39, Shanghai Xiao Fang Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Drug Manufacturers company?
The median 5-Year Yield-on-Cost % among Drug Manufacturers companies is 2.39, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xiao Fang Pharmaceutical Co's current 5-Year Yield-on-Cost % of 4.63 is 93.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Shanghai Xiao Fang Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median 5-Year Yield-on-Cost % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xiao Fang Pharmaceutical Co's current 5-Year Yield-on-Cost % is 4.63, which is 37% below median its own 10-year median of 7.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xiao Fang Pharmaceutical Co stock overvalued right now?
Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207) has a current 5-Year Yield-on-Cost % of 4.63. The current 5-Year Yield-on-Cost % is 4.63, which is 37% below median its 10-year median of 7.39 and 93.7% above the Drug Manufacturers industry median of 2.39. Shanghai Xiao Fang Pharmaceutical Co's overall GF Score™ is 41/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Shanghai Xiao Fang Pharmaceutical Co (SHSE:603207), the current 5-Year Yield-on-Cost % is 4.63 as of Aug. 31, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603207 has been successfully added to your 
